Venclexta
Venclexta ingredients
| Active ingredient | Strength |
|---|---|
| Venetoclax | 50 mg/1, 10 mg/1, 100 mg/1 |
What Venclexta is used for
The FDA lists the approved uses on the official label (below). In the EU, venetoclax is approved as Venclyxto for:
Venclyxto is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (CLL): in combination with acalabrutinib with or without obinutuzumab in combination with obinutuzumab in combination with ibrutinib Venclyxto in combination with rituximab is indicated for the treatment of adult patients with CLL who have received at least one prior therapy. Venclyxto monotherapy is indicated for the treatment of CLL: in the presence of 17p deletion or TP53 mutation in adult patients who are unsuitable for or have failed a B cell receptor pathway inhibitor, or in the absence of 17p deletion or TP53 mutation in adult patients who have failed both chemoimmunotherapy and a B cell receptor pathway inhibitor. Venclyxto in combination with a hypomethylating agent is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (AML) w…
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Venclexta
- Generic name
- Venetoclax
- Made by
- AbbVie Inc.
- Forms
- Tablet, Film Coated
- Given
- Oral
- Drug class
- BCL-2 Inhibitor
- FDA approval
- New drug application (NDA) NDA208573
- On the US market since
- 2016
Official information
- Venclexta prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Venetoclax)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Venclexta?
Venclexta (Venetoclax) is a cancer medicine made by AbbVie Inc., approved by the US FDA.
What are the ingredients of Venclexta?
Venclexta contains Venetoclax (50 mg/1, 10 mg/1, 100 mg/1).
Is Venclexta approved in Europe?
The same active substance is approved in the EU as Venclyxto.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA